en
Scientific article
English

The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: comparing misoprostol versus dinoprostone

Published inJournal of maternal-fetal & neonatal medicine, vol. 23, no. 9, p. 988-993
Publication date2010
Abstract

Recent data have raised concern about the safety of using misoprostol in women with preeclampsia. We wanted to evaluate the risk of placental abruption in women with preeclampsia undergoing cervical ripening with misoprostol compared to dinoprostone.

Keywords
  • Abruptio Placentae/epidemiology/etiology
  • Administration, Intravaginal
  • Adolescent
  • Adult
  • Cervical Ripening/drug effects
  • Dinoprostone/administration & dosage/adverse effects
  • Female
  • Humans
  • Incidence
  • Labor, Induced/methods
  • Middle Aged
  • Misoprostol/administration & dosage/adverse effects
  • Oxytocics/administration & dosage/adverse effects
  • Pre-Eclampsia/epidemiology/therapy
  • Pregnancy
  • Prostaglandins/administration & dosage/adverse effects
  • Risk
  • Young Adult
Citation (ISO format)
MARTINEZ DE TEJADA WEBER, Begona et al. The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: comparing misoprostol versus dinoprostone. In: Journal of maternal-fetal & neonatal medicine, 2010, vol. 23, n° 9, p. 988–993. doi: 10.3109/14767050903443475
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1476-4954
615views
0downloads

Technical informations

Creation05/25/2012 10:57:00 AM
First validation05/25/2012 10:57:00 AM
Update time03/14/2023 5:36:45 PM
Status update03/14/2023 5:36:45 PM
Last indexation01/15/2024 11:56:10 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack